[1]
R. Soda, A. Costanzo, M. Cantonetti, A. Orlandi, L. Bianchi, and S. Chimenti, “Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody”, Acta Derm Venereol, vol. 81, no. 3, pp. 207–208, May 2001.